Campen, Matthew J
- University of New Mexico Health Sciences Center · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,106
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$2.8M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#2,106
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Campen, Matthew J as a PI. Multi-PI records show the full award amount for context.
- 5UL1TR001449-09UL1Contact PIUNM HSC Clinical and Translational Science CenterUniversity of New Mexico Health Sciences Center · Pathology (NIH department code)$2.7Maward amount
- 3UL1TR001449-09S1UL1Contact PIUNM HSC Clinical and Translational Science CenterUniversity of New Mexico Health Sciences Center · Pathology (NIH department code)$45.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Campen, Matthew J as a PI.
FY2023 award administered by University of New Mexico Health Sciences Center (NM).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardUniversity of New Mexico Health Sciences Center
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #991
- 2022Entered Top 25% NationallyRanked #991
- 2022Entered Top 10% NationallyRanked #991
- 2022Entered Top 5% NationallyRanked #991
- 2023$5M Cumulative Funding